TEC-话题@MedSci

#TEC#

484篇内容 | 2709人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652484, encodeId=d12b1652484c0, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotechnol：单碱基编辑器助力肝病治疗, objectType=article, longId=212355, objectId=411a21235546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411a21235546, replyNumber=0, likeNumber=71, createdTime=2021-11-22, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411a21235546, moduleTitle=Nat Biotechnol：单碱基编辑器助力肝病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411a21235546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652504, encodeId=7a7016525040a, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=肿瘤期刊推荐：TECHNOL CANCER RES T, objectType=article, longId=219302, objectId=d04221930290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d04221930290, replyNumber=0, likeNumber=60, createdTime=2022-01-05, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d04221930290, moduleTitle=肿瘤期刊推荐：TECHNOL CANCER RES T, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d04221930290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652463, encodeId=9aa81652463a5, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=以色列全新真实世界研究证实BioNTech疫苗在首剂后有效率为85％，力证推迟接种二剂, objectType=article, longId=207323, objectId=970820e3233e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=970820e3233e, replyNumber=0, likeNumber=77, createdTime=2022-01-22, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=970820e3233e, moduleTitle=以色列全新真实世界研究证实BioNTech疫苗在首剂后有效率为85％，力证推迟接种二剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=970820e3233e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652469, encodeId=5a72165246947, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Arthritis Rheumatol：DETECT算法可准确预测系统性硬化症患者的肺动脉高压风险, objectType=article, longId=209008, objectId=d9e22090083a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9e22090083a, replyNumber=0, likeNumber=104, createdTime=2021-10-04, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9e22090083a, moduleTitle=Arthritis Rheumatol：DETECT算法可准确预测系统性硬化症患者的肺动脉高压风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9e22090083a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652497, encodeId=f07d165249e03, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, objectType=article, longId=217335, objectId=d79721e335a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d79721e335a4, replyNumber=0, likeNumber=85, createdTime=2022-06-20, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d79721e335a4, moduleTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d79721e335a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652461, encodeId=1c1416524611b, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=WCLC 2020：Patritumab Deruxtecan治疗EGFR突变的NSCLC患者, objectType=article, longId=206511, objectId=cbe82065113c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbe82065113c, replyNumber=0, likeNumber=110, createdTime=2021-03-09, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbe82065113c, moduleTitle=WCLC 2020：Patritumab Deruxtecan治疗EGFR突变的NSCLC患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbe82065113c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652486, encodeId=1dc3165248678, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotech：黑科技！哈佛大学发明可检测新冠病毒的口罩，效果媲美核酸检测，基于张锋的夏洛克系统, objectType=article, longId=213575, objectId=17a82135e537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17a82135e537, replyNumber=0, likeNumber=87, createdTime=2021-08-23, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17a82135e537, moduleTitle=Nat Biotech：黑科技！哈佛大学发明可检测新冠病毒的口罩，效果媲美核酸检测，基于张锋的夏洛克系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17a82135e537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652475, encodeId=551816524e560, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=NEJM：ADC药物Sacituzumab govitecan一线治疗转移性三阴性乳腺癌, objectType=article, longId=210410, objectId=eb7421041030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb7421041030, replyNumber=0, likeNumber=107, createdTime=2021-09-07, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb7421041030, moduleTitle=NEJM：ADC药物Sacituzumab govitecan一线治疗转移性三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb7421041030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=英国授权辉瑞/ BioNTech研发的新冠疫苗全面使用, objectType=article, longId=204055, objectId=0d39204055c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d39204055c5, replyNumber=0, likeNumber=96, createdTime=2021-01-03, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d39204055c5, moduleTitle=英国授权辉瑞/ BioNTech研发的新冠疫苗全面使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d39204055c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652453, encodeId=43af165245332, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=年底前或将打上疫苗？辉瑞和BioNTech向FDA提交申请, objectType=article, longId=204193, objectId=34e920419394, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e920419394, replyNumber=0, likeNumber=74, createdTime=2021-03-31, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e920419394, moduleTitle=年底前或将打上疫苗？辉瑞和BioNTech向FDA提交申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34e920419394)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652500, encodeId=33d11652500e1, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Appl Microbiol Biotechnol：柔性冷等离子体装置可有效且安全的减少细菌促进慢性伤口的愈合, objectType=article, longId=217873, objectId=cf1121e8731e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf1121e8731e, replyNumber=0, likeNumber=106, createdTime=2022-08-25, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf1121e8731e, moduleTitle=Appl Microbiol Biotechnol：柔性冷等离子体装置可有效且安全的减少细菌促进慢性伤口的愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf1121e8731e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652479, encodeId=5b4616524e977, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化, objectType=article, longId=211060, objectId=0efc211060e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0efc211060e6, replyNumber=0, likeNumber=80, createdTime=2022-02-18, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0efc211060e6, moduleTitle=2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0efc211060e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652494, encodeId=9c911652494b2, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Nanotech：原来肿瘤分“冷”“热”，这项给肿瘤“加温”的纳米技术有望成为癌症克星！, objectType=article, longId=216108, objectId=d11a216108c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d11a216108c9, replyNumber=0, likeNumber=88, createdTime=2022-06-14, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d11a216108c9, moduleTitle=Nat Nanotech：原来肿瘤分“冷”“热”，这项给肿瘤“加温”的纳米技术有望成为癌症克星！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d11a216108c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652480, encodeId=4dea1652480a5, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗, objectType=article, longId=211118, objectId=aa5d21111858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa5d21111858, replyNumber=0, likeNumber=66, createdTime=2022-01-26, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa5d21111858, moduleTitle=BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa5d21111858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652456, encodeId=b14d165245625, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Coagulo Medical Technologies宣布获得650万美元融资，用于加快交付颠覆性凝血诊断平台, objectType=article, longId=204841, objectId=f1b7204841e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1b7204841e4, replyNumber=0, likeNumber=81, createdTime=2021-02-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1b7204841e4, moduleTitle=Coagulo Medical Technologies宣布获得650万美元融资，用于加快交付颠覆性凝血诊断平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1b7204841e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652477, encodeId=be6916524e7ab, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=欧盟将2年内购买至少18亿剂辉瑞与BioNtech新冠疫苗, objectType=article, longId=211027, objectId=c67821102e60, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67821102e60, replyNumber=0, likeNumber=76, createdTime=2022-04-07, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67821102e60, moduleTitle=欧盟将2年内购买至少18亿剂辉瑞与BioNtech新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67821102e60)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652441, encodeId=9d54165244174, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段, objectType=article, longId=201860, objectId=7aa320186063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa320186063, replyNumber=0, likeNumber=67, createdTime=2020-10-12, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa320186063, moduleTitle=GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa320186063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652489, encodeId=be33165248938, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=放射治疗器官限量（QUANTEC）, objectType=article, longId=214413, objectId=d83621441304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d83621441304, replyNumber=0, likeNumber=45, createdTime=2021-12-27, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d83621441304, moduleTitle=放射治疗器官限量（QUANTEC）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d83621441304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652488, encodeId=808f165248823, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, objectType=article, longId=214285, objectId=9f1121428517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1121428517, replyNumber=0, likeNumber=75, createdTime=2022-06-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1121428517, moduleTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1121428517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652454, encodeId=4a2216524540a, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, objectType=article, longId=204415, objectId=8ae32044156a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae32044156a, replyNumber=0, likeNumber=83, createdTime=2021-05-23, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae32044156a, moduleTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae32044156a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TEC

2020-05-29

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotechnol：单碱基编辑器助力肝病治疗

2021-11-22

shock_melon (审核中...)

前往app查看评论内容

#TEC#

肿瘤期刊推荐：TECHNOL CANCER RES T

2022-01-05

shock_melon (审核中...)

前往app查看评论内容

#TEC#

以色列全新真实世界研究证实BioNTech疫苗在首剂后有效率为85％，力证推迟接种二剂

2022-01-22

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Arthritis Rheumatol：DETECT算法可准确预测系统性硬化症患者的肺动脉高压风险

2021-10-04

shock_melon (审核中...)

前往app查看评论内容

#TEC#

J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合

2022-06-20

shock_melon (审核中...)

前往app查看评论内容

#TEC#

WCLC 2020：Patritumab Deruxtecan治疗EGFR突变的NSCLC患者

2021-03-09

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotech：黑科技！哈佛大学发明可检测新冠病毒的口罩，效果媲美核酸检测，基于张锋的夏洛克系统

2021-08-23

shock_melon (审核中...)

前往app查看评论内容

#TEC#

NEJM：ADC药物Sacituzumab govitecan一线治疗转移性三阴性乳腺癌

2021-09-07

shock_melon (审核中...)

前往app查看评论内容

#TEC#

英国授权辉瑞/ BioNTech研发的新冠疫苗全面使用

2021-01-03

shock_melon (审核中...)

前往app查看评论内容

#TEC#

年底前或将打上疫苗？辉瑞和BioNTech向FDA提交申请

2021-03-31

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Appl Microbiol Biotechnol：柔性冷等离子体装置可有效且安全的减少细菌促进慢性伤口的愈合

2022-08-25

shock_melon (审核中...)

前往app查看评论内容

#TEC#

2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化

2022-02-18

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Nanotech：原来肿瘤分“冷”“热”，这项给肿瘤“加温”的纳米技术有望成为癌症克星！

2022-06-14

shock_melon (审核中...)

前往app查看评论内容

#TEC#

BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗

2022-01-26

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Coagulo Medical Technologies宣布获得650万美元融资，用于加快交付颠覆性凝血诊断平台

2021-02-21

shock_melon (审核中...)

前往app查看评论内容

#TEC#

欧盟将2年内购买至少18亿剂辉瑞与BioNtech新冠疫苗

2022-04-07

shock_melon (审核中...)

前往app查看评论内容

#TEC#

GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段

2020-10-12

shock_melon (审核中...)

前往app查看评论内容

#TEC#

放射治疗器官限量（QUANTEC）

2021-12-27

shock_melon (审核中...)

前往app查看评论内容

#TEC#

复星医药与BioNTech研发的新冠疫苗通过中国专家组审核

2022-06-21

shock_melon (审核中...)

前往app查看评论内容

#TEC#

NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权

2021-05-23

科室
- - 订阅+
  - 更多科室
工具
服务